Movano (Movano) Days Sales Outstanding

: 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

Movano's average Accounts Receivable for the three months ended in Dec. 2023 was $0.00 Mil. Movano's Revenue for the three months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Movano's Days Sales Outstanding or its related term are showing as below:

MOVE's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 63.91
* Ranked among companies with meaningful Days Sales Outstanding only.

Movano's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Movano Days Sales Outstanding Historical Data

The historical data trend for Movano's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Movano Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding														-	-	-	-	-

Competitive Comparison

For the Medical Devices subindustry, Movano's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Movano Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Movano's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Movano's Days Sales Outstanding falls into.

Movano Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Movano's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Movano's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Movano (NAS:MOVE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Movano Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Movano's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano (Movano) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

6800 Koll Center Parkway, Pleasanton, CA, USA, 94566

Website

https://www.movano.com

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.

Executives

Jeremy Cogan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman	director, officer: CEO and President	207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn	director	10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro	director	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte	director	111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero	director	C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust	10 percent owner	6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin	10 percent owner	303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc	10 percent owner	401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho	10 percent owner	C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016